{
  "data": {
    "id": "stat_0QMFAF1MGRT1XPHY10KD7TPG9E",
    "url": "https://statorigin.org/stat/stat_0QMFAF1MGRT1XPHY10KD7TPG9E",
    "indicator": {
      "slug": "pharmaceutical-and-medicine-manufacturing-company-funded-r-d",
      "name": "Pharmaceutical and medicine manufacturing company-funded R&D",
      "definition": "Cost of research and development paid for and performed by pharmaceutical and medicine manufacturing companies."
    },
    "industry": [
      {
        "slug": "pharmaceuticals",
        "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
        "isic": "C21",
        "is_primary": true
      }
    ],
    "region": {
      "code": "US",
      "name": "United States",
      "type": "country"
    },
    "period": {
      "start": "2023-01-01",
      "end": "2023-12-31",
      "type": "year"
    },
    "value": 114225,
    "value_text": "114,225",
    "unit": "USD",
    "currency": "USD",
    "scale": "million",
    "value_type": "actual",
    "source": {
      "org": "National Center for Science and Engineering Statistics",
      "org_short_name": "NCSES",
      "org_url": "https://ncses.nsf.gov",
      "org_tier": 1,
      "document_title": "Business R&D Performance in the United States Increases to $722 Billion in 2023",
      "document_url": "https://ncses.nsf.gov/pubs/nsf25353",
      "document_type": "press_release",
      "locator": "Table 2. Funds spent for business R&D performed in the United States, by source of funds, selected industry, and company size: 2023",
      "quote": "Pharmaceuticals and medicines, 3254 125,986 empty 114,225 empty 11,761 empty 549 empty 2,104 empty 9,029 empty 79 empty",
      "published_date": null,
      "accessed_at": "2026-09-17",
      "license": "see-source",
      "url_status": "ok"
    },
    "verification": "verified",
    "verified_by": "seed:auto-extract-v1",
    "verified_at": "2026-09-17T07:16:01.811Z",
    "confidence": 0.9,
    "is_secondhand": false,
    "supersedes": null,
    "superseded_by": null,
    "is_current": true,
    "citation": {
      "apa": "National Center for Science and Engineering Statistics. (2023). Business R&D Performance in the United States Increases to $722 Billion in 2023. Retrieved September 17, 2026, from https://ncses.nsf.gov/pubs/nsf25353. Via StatOrigin, https://statorigin.org/stat/stat_0QMFAF1MGRT1XPHY10KD7TPG9E",
      "bibtex": "@misc{ncses2023pharmaceutical7tpg9e,\n  author       = {{National Center for Science and Engineering Statistics}},\n  title        = {Business R\\&D Performance in the United States Increases to \\$722 Billion in 2023},\n  year         = {2023},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_0QMFAF1MGRT1XPHY10KD7TPG9E},\n  note         = {Original source: https://ncses.nsf.gov/pubs/nsf25353. Accessed September 17, 2026.}\n}"
    },
    "updated_at": "2026-09-17T07:16:01.811Z",
    "contested_by": [],
    "related": []
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 1
  }
}